Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,628
datasets available to search
ShareScore release 0.9.0
Dataset results
1,628 results for “type safety”
Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan
ClinicalTrials.gov study NCT02648217. IPD Sharing: Not stated. Countries: 6. Publications: 3.
Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes
ClinicalTrials.gov study NCT01289119. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines
ClinicalTrials.gov study NCT01189747. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
ClinicalTrials.gov study NCT02298192. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Safety and Efficacy of Albiglutide in Type 2 Diabetes
ClinicalTrials.gov study NCT00849056. IPD Sharing: YES. Countries: 6. Publications: 1.
Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
ClinicalTrials.gov study NCT02642159. IPD Sharing: Not stated. Countries: 15. Publications: 5.
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin
ClinicalTrials.gov study NCT03021187. IPD Sharing: YES. Countries: 10. Publications: 5.
Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01289990. IPD Sharing: Not stated. Countries: 19. Publications: 5.
Safety and Efficacy of Empagliflozin (BI 10773) in Type 1 Diabetes Mellitus Patients With or Without Renal Hyperfiltration
ClinicalTrials.gov study NCT01392560. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.
ClinicalTrials.gov study NCT00727857. IPD Sharing: Not stated. Countries: 4. Publications: 2.
Trial Assessing Efficacy, Safety and Tolerability of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition in Paediatric Subjects With Genetic Low-Density Lipoprotein (LDL) Disorders
ClinicalTrials.gov study NCT02392559. IPD Sharing: YES. Countries: 26. Publications: 4.
Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
ClinicalTrials.gov study NCT01922258. IPD Sharing: YES. Countries: 9. Publications: 5.
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
ClinicalTrials.gov study NCT03047395. IPD Sharing: YES. Countries: 17. Publications: 4.
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease
ClinicalTrials.gov study NCT02540993. IPD Sharing: Not stated. Countries: 48. Publications: 28.
Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes
ClinicalTrials.gov study NCT02825251. IPD Sharing: Not stated. Countries: 9. Publications: 3.
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT02305381. IPD Sharing: Not stated. Countries: 6. Publications: 10.
Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens
ClinicalTrials.gov study NCT01365507. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01011868. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
ClinicalTrials.gov study NCT01603459. IPD Sharing: Not stated. Countries: 8. Publications: 3.
Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT01619059. IPD Sharing: Not stated. Countries: 9. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.